Investigational Site Number 840009

Newark, New Jersey 07112

0 studies enrolling now · 1 studies all time

What they study most

Hematopoietic Neoplasm

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed